Aarti Drugs Limited (BOM: 524348)

Aarti Drugs Statistics

Total Valuation

Aarti Drugs has a market cap or net worth of INR 48.63 billion. The enterprise value is 54.07 billion.

Market Cap	48.63B
Enterprise Value	54.07B

Important Dates

The next estimated earnings date is Friday, October 18, 2024.

Earnings Date	Oct 18, 2024
Ex-Dividend Date	n/a

Share Statistics

Aarti Drugs has 91.94 million shares outstanding. The number of shares has decreased by -0.89% in one year.

Shares Outstanding	91.94M
Shares Change (YoY)	-0.89%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	47.22%
Owned by Institutions (%)	8.26%
Float	35.06M

Valuation Ratios

The trailing PE ratio is 31.11 and the forward PE ratio is 20.83.

PE Ratio	31.11
Forward PE	20.83
PS Ratio	2.00
PB Ratio	3.80
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	34.48
EV / Sales	2.23
EV / EBITDA	17.90
EV / EBIT	21.66
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	44.02
Debt / EBITDA	1.87
Debt / FCF	n/a
Interest Coverage	7.41

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	8.55%
Revenue Per Employee	22.77M
Profits Per Employee	1.47M
Employee Count	1,064
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.67%
50-Day Moving Average	536.57
200-Day Moving Average	507.32
Relative Strength Index (RSI)	45.10
Average Volume (20 Days)	57,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aarti Drugs had revenue of INR 24.23 billion and earned 1.57 billion in profits. Earnings per share was 17.01.

Revenue	24.23B
Gross Profit	8.32B
Operating Income	2.50B
Pretax Income	2.16B
Net Income	1.57B
EBITDA	3.02B
EBIT	2.50B
Earnings Per Share (EPS)	17.01

Balance Sheet

The company has 207.70 million in cash and 5.64 billion in debt, giving a net cash position of -5.44 billion or -59.12 per share.

Cash & Cash Equivalents	207.70M
Total Debt	5.64B
Net Cash	-5.44B
Net Cash Per Share	-59.12
Equity (Book Value)	12.82B
Book Value Per Share	139.39
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 34.32%, with operating and profit margins of 10.30% and 6.47%.

Gross Margin	34.32%
Operating Margin	10.30%
Pretax Margin	8.91%
Profit Margin	6.47%
EBITDA Margin	12.47%
EBIT Margin	10.30%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.19%.

Dividend Per Share	1.00
Dividend Yield	0.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.89%
Shareholder Yield	1.08%
Earnings Yield	3.21%
FCF Yield	n/a

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	4